Search Results for: Tilray
Tilray Medical Receives Approval to Extend Market Authorization in Italy
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis…
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis…
Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results
FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency…
Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle…
Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note
Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY), a leading global…
Tilray Brands Reports Third Quarter Fiscal Year 2022 Financial Results
Profitable Quarter Includes Net Income of $52.5 Million and Adjusted EBITDA of $10.1 Million; 12th Consecutive…
Tilray Brands to Announce Third Quarter Fiscal 2022 Financial Results on April 6, 2022
Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY), a leading global cannabis-lifestyle…
Tilray Medical Expands Offering in Malta and Launches First Medical Cannabis Oil Products in Market
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and…
Tilray to Acquire Hexo Corp.’s Senior Secured Convertible Notes – Form Partnership
Commercial and financial alliance would bring together Canada’s top two cannabis market share leaders to…
Tilray Launches Medical Cannabis Products in Malta
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle…
Recent Comments